Viewing Study NCT00074932


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-02 @ 12:29 AM
Study NCT ID: NCT00074932
Status: COMPLETED
Last Update Posted: 2014-02-06
First Post: 2003-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module